IL6 and head and neck squamous cell carcinoma: The colony assay demonstrated a clear increase in survival and radioresistance of HNSCC cell lines pre-treated with IL-6 or FbCM compared with control cells, with a statistically significant increase in survival fraction at a dose of 4 Gy.